Relationship of perfluoroalkyl chemicals with chronic obstructive pulmonary disease: A cross-sectional study
Toxicology and Industrial Health · 2025
DOI: 10.1177/07482337251315216 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Toxicology and Industrial Health, 2025. Verfasst von Xuefang Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Zhejiang Hospital, Hangzhou, China. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Fluorocarbons, Alkanesulfonic Acids, Environmental Pollutants. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Medical and Health Science and Technology Plan of Zhejiang Province, Zhejiang Province Traditional Chinese Medicine Science and Technology Plan.
Themen: COPD
Abstract (Originalsprache)
Perfluoroalkyl chemicals are one of the most stable substances in industry and have become ubiquitous contaminants owing to their persistence in the environment. This study enrolled 1,953 participants aged ≥40 years old using data from the National Health and Nutrition Examination Survey (NHANES). We selected four perfluoroalkyl chemicals with a detection frequency of more than 80%, including perfluorohexane sulfonic acid (PFHxS), perfluorononanoic acid (PFNA), perfluorooctanoic acid (PFOA), and perfluorooctane sulfonic acid (PFOS). Multivariate logistic regression was performed to determine the relationship of serum perfluoroalkyl chemicals with COPD and airflow limitation. We evaluated the interaction between perfluoroalkyl chemicals and lung function using multivariate linear regression analyses. Our results showed that the prevalence of COPD was not significantly related to serum PFHxS, PFNA, PFOA, and PFOS. Airflow limitation was positively linked with serum PFHxS, PFOA, and PFOS. However, these significant differences were not robust after adjustment of all confounders of interest. Serum PFHxS, PFOA, and PFOS were all positively related to the forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC), and peak expiratory flow (PEF). However, only PFOA remained significantly linked with the FEV1 and FVC after covariate adjustment. These results indicated that there was no significant interaction between exposure to perfluoroalkyl chemicals and the prevalence of COPD. Higher levels of serum PFOA appeared to be related to higher measures of FEV1 and FVC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases, Zhejiang Hospital, Hangzhou, China.
- Department of Respiratory Diseases, Zhejiang Hospital, Hangzhou, China.
ORCID-Profile: Wu Ye
Förderung
- Medical and Health Science and Technology Plan of Zhejiang Province
- Zhejiang Province Traditional Chinese Medicine Science and Technology Plan
Zitieren
APA
Li, X., Li, Z., Ye, J., & Ye, W. (2025). Relationship of perfluoroalkyl chemicals with chronic obstructive pulmonary disease: A cross-sectional study. Toxicology and Industrial Health. https://doi.org/10.1177/07482337251315216
Vancouver
Li X, Li Z, Ye J, Ye W. Relationship of perfluoroalkyl chemicals with chronic obstructive pulmonary disease: A cross-sectional study. Toxicology and Industrial Health. 2025. doi:10.1177/07482337251315216
BibTeX
@article{Li2025,
author = {Li, Xuefang and Li, Zhijun and Ye, Jian and Ye, Wu},
title = {Relationship of perfluoroalkyl chemicals with chronic obstructive pulmonary disease: A cross-sectional study},
journal = {Toxicology and Industrial Health},
year = {2025},
doi = {10.1177/07482337251315216}
}
EUVIMED